Matthew Hawryluk is Director at Predictive Oncology Inc. (POAI). They have made 1 open-market trade across 1 company since 2024, most recently 2026-10-01.
CIK 0001754470
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GRTS | SELL | 2024-05-16 | 2024-05-17 | $0.75 | $7K | -5.6% | -3.7% | -32.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.